AGP-GROUP
A company with a glazing heritage that started in Berlin a century ago returns to Europe as a worldwide player in the automotive fast-evolving industry. Following a minority investment from Goldman Sachs and shortly after acquiring European glazing manufacturer Soliver NV in 2018, AGP Group consolidates its European footprint by opening eGlass 2.0: a state-of-the-art plant designed to manufacture high-tech glazing tailored for electric and autonomous vehicles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191004005196/en/
“Customers from around the world have come to visit our plant and we have captured their attention with the amount of technology incorporated in eGlass 2.0, which makes it unique in the industry. This scale of production and level of automation, with no human interaction with the product along the line, will allow us to bring more affordable switchable exterior glazing to the market, with the goal of accelerating the penetration of this technology within the automotive industry. eGlass 2.0 is also capable of manufacturing lightweight coated glazing to increase the driving range of electric vehicles”
- Arturo Mannheim, AGP Group CEO
Innovation-driven and customer centered, AGP has rapidly developed high-end technologies for the rising demand in electrification, connectivity, shared mobility and autonomous driving. With this new 40.000m² facility, the company estimates the production of up to 3.000.000m² glass per year, featuring large and complex shapes, switchable glass technologies, lightweight compositions incorporating aluminosilicate glass, coated products, among others.
Today, AGP has 6 manufacturing plants, commercial offices in 20 countries, and a Tech Innovation Center in Germany.
About AGP Group
AGP Group is one of the world’s leading glazing manufacturers. Over the last 50 years, AGP has developed a large portfolio of products for the automotive, marine, mass transit, and military markets. With 2,000 employees from 20 different nationalities, the company offers services to 650 customers globally. For more information, visit www.agpglass.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20191004005196/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP3606.1.2026 12:30:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic collaboration, with Radial Health, Inc., a growing national network of interventional psychiatry practices leveraging technology and operations expertise to optimize models of care delivery. This collaboration will further help to inform the development of scalable delivery models for investigational COMP360 psilocybin treatment, if FDA approved. The agreement with Radial expands the set of collaborations that Compass has established representing a broad spectrum of settings where people living with mental health conditions receive their care in the United States. Radial is building a national network of clinics across the U.S., delivering interventional, evidence-based treatments for mental health conditions. The co-founders have a mission-driven background in designing customer-centric care and bui
Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries6.1.2026 11:30:00 CET | Press release
A Suite of Solutions Leveraging Advanced AI with Company’s Deep Domain Knowledge of Social Infrastructure Hitachi, Ltd. (TSE:6501, "Hitachi") today introduced HMAX by Hitachi at CES 2026. HMAX by Hitachi is a suite of next-generation solutions that brings the power of AI to social infrastructure. By harnessing vast data from physical and digital assets, integrating advanced AI, and applying Hitachi’s unmatched domain expertise, HMAX tackles the most complex social infrastructure challenges—maximizing outcomes and value for our clients and society. These solutions are derived from the formalized HMAX design principles, integrating a dynamic collection of advanced technologies and a robust partner ecosystem that helps elevate end-system reliability and performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106885363/en/ HMAX by Hitachi: the suite of next-generation solutions that brings the power of AI to social infras
Pandorum Technologies and Nucelion Therapeutics Announce Strategic Collaboration to Manufacture Exosome-Based Tissue Regenerative Therapy for Ocular Diseases in APAC Markets6.1.2026 11:00:00 CET | Press release
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue regeneration, today announced a strategic collaboration with Hyderabad based Nucelion Therapeutics, a specialized contract research, development and manufacturing organization (CRDMO), to expand manufacturing capabilities for Pandorum’s exosome-based therapeutic platform across the Asia-Pacific (APAC) region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106214233/en/ This strategic collaboration aligns with a shared vision, as Pandorum’s asset(s) progress toward clinical trials. By leveraging Nucelion Therapeutics’ manufacturing capabilities, the partnership supports regional supply and regulatory readiness, marking a strategic step forward. Furthermore, it reaffirms India’s growing capability to develop and manufacture cutting-edge biologic therapies for the world. “Pandorum is building a gl
KAYTUS Completes 100-Cabinet Liquid-Cooled Data Center in Europe in Four Months6.1.2026 09:02:00 CET | Press release
KAYTUS turnkey modular solution delivered with onsite professional services, improved high-density liquid cooling cluster performance by 20%, and deployment efficiency by 80%. KAYTUS announced that it has accelerated the deployment of large-scale liquid-cooled AI data centers through its integrated turnkey service. By combining deployment and commissioning, KAYTUS delivers a one-stop, end-to-end service, from installation to optimization and launch. Recently, KAYTUS completed the delivery of a 100-cabinet, high-density liquid-cooled AI data center in Europe in just four months, up to 80% faster than traditional deployment models. Through professional performance testing and tuning, overall system performance was improved by 20%, enabling a stable, high-efficiency business launch through on-site optimization and customization. This accelerated and resilient delivery addresses urgent AI infrastructure timelines and provides a scalable blueprint for deploying high-density liquid-cooled cl
Kashiv BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conference6.1.2026 09:00:00 CET | Press release
Kashiv BioSciences, LLC (“Kashiv”), a vertically integrated biopharmaceutical company, today announced that Dr. Sandeep Athalye, Global Chief Executive Officer, and Dr. Paras Vasanani, Head of Business Development, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 14, 2026, at 11:00 a.m. PST. 44th Annual J.P. Morgan Healthcare Conference – Kashiv BioSciences Company Presentation Date: Wednesday, January 14, 2026 Time: 11:00 - 11:25 a.m. PST Location: Golden Gate Conference Room – The Westin St. Francis Hotel, San Francisco, California About Kashiv BioSciences: Kashiv BioSciences, LLC is a vertically integrated biopharmaceutical company with numerous commercial and advanced clinical-stage assets and is among the few U.S.-based companies to both manufacture and receive marketing authorization for multiple biosimilars. Kashiv BioSciences, LLC in the USA, and its subsidiaries in India (together “Kashiv BioSciences”) operat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom